ASTM E3483
Standard Test Method for Evaluating the Impact of Nanomaterials on Phagocytic Function in Vitro
Available Formats:
- Availability: Immediate Download
- Language: English
- License Type: Single User
- Updates: Not Included
- Availability: Request Quote
- Language: English
- License Type: Enterprise / Multi User
- Updates: Included
About This Item
ASTM E3483 is the ASTM standard titled Standard Test Method for Evaluating the Impact of Nanomaterials on Phagocytic Function in Vitro. It provides a structured way to assess whether nanomaterials may affect phagocytic activity under controlled laboratory conditions. This is important for material evaluation, biological safety screening, and consistency in test reporting. ASTM E3483 helps organizations use a common technical approach when comparing results across studies or product-development workflows.
Purpose of ASTM E3483
The purpose of this standard is to define a test method for examining how nanomaterials interact with phagocytic function in vitro. By focusing on a controlled test environment, it supports more consistent evaluation of potential biological effects and helps reduce variability in how results are generated and interpreted. ASTM E3483 is relevant when a clear, repeatable method is needed to examine possible impacts on phagocytic activity during research, development, or safety-oriented assessment.
Common use cases of ASTM E3483
This standard is commonly used in laboratory settings where nanomaterials are being screened or compared for their interaction with immune-related cellular function. It may support product development, preclinical evaluation, and quality control workflows that require a defined in vitro method. ASTM E3483 is also useful when testing teams need a shared framework for reporting results, reviewing material behavior, or documenting biological response in a way that is easier to compare across projects.
Why ASTM E3483 matters
ASTM E3483 matters because it supports more reliable and repeatable evaluation of nanomaterials in a biologically relevant test context. A standardized method can improve consistency in testing, strengthen documentation for procurement or internal review, and help reduce uncertainty when comparing materials or batches. For organizations working with nanomaterials, this ASTM standard can be an important tool for technical decision-making, compliance support, and risk reduction.
- In vitro evaluation of phagocytic function
- Nanomaterial biological response screening
- Repeatable laboratory test method
- Support for comparative reporting
- Quality and safety assessment workflows
- Publication Date: 2025-05-07
- Publisher: ASTM
Need This Standard?
Request a personalized quote today to receive the latest edition in PDF or other available formats.
Need This Standard?
Request a personalized quote today to receive the latest edition in PDF or other available formats.
Summarize with AI
Get quick summaries using your favorite AI engine.
Online Standart Disclaimer
OnlineStandart.com is an authorized reseller of international standards through partnerships with authorized distributors. We do not own the copyrights or trademarks of the standards we sell, including but not limited to those of API, ASHRAE, BSI, SAE, ASTM, IEEE, IEC, ASME, ISO, and others.
All product names, logos, and brands are property of their respective owners. All company, product, and service names used on this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.
The content provided on this website is for informational purposes only and is intended to promote our reselling services. OnlineStandart.com is not affiliated with or endorsed by any of the standard organizations unless explicitly stated.